Headlines
Extracellular vesicle-mediated VEGF-A mRNA delivery rescues ischaemic injury with low immunogenicity

A novel gene therapy for ischemic heart disease based on engineered external vesicles with high efficiency and low immunogenicity

Ischemic injury is the number one cause of death and disease in the world, including the United States and China, and vascular endothelial growth factor (VEGF) gene therapy holds promise for patients with ischemic injury. However, the high immunogenicity of traditional viral vectors (such as adeno-associated virus AAV) and the low expression efficiency of lipid…

Read More
liver

Effective liver protection drugs you need to know

[Must see] Efficient liver protection, these drugs you must know! Complete analysis of pharmaceutical care Clinically, drugs that improve liver function, promote liver cell regeneration and enhance liver detoxification function are classified as hepatoprotective drugs. There are many reasons for liver cell damage, therefore, in the liver protection treatment, the cause should be removed first,…

Read More